The HCT 116 control and PCTK1-KO cells were treated with various doses of 5-fluouracil (5-FU) and irinotecan (IRI), one of the standard first-line chemotherapeutics for CRC. The gene discussed is CDK16; the disease is colorectal carcinoma.